UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity

Fertility and sterility, 1999-07, Vol.72 (1), p.115-120

1999

Volltextzugriff (PDF)

effects of short intensive exercise on plasma free amino acids in standardbred trotters

Journal of animal physiology and animal nutrition, 2009-04, Vol.93 (2), p.165-173

2009

Volltextzugriff (PDF)

preliminary study on the changes in some potential markers of muscle‐cell degradation in sub‐maximally exercised horses supplemented with a protein and amino acid mixture

Journal of animal physiology and animal nutrition, 2011-10, Vol.95 (5), p.664-675

2011

Volltextzugriff (PDF)

Changes in intramuscular amino acid levels in submaximally exercised horses - a pilot study

Journal of animal physiology and animal nutrition, 2010-08, Vol.94 (4), p.455-464

2010

Volltextzugriff (PDF)

Contraceptive efficacy and safety of a low-dose oral contraceptive, (0.03 mg ethinyl oestradiol and 2 mg chlormadinone acetate) Belara®, over three medication cycles

The European journal of contraception & reproductive health care, 2008, Vol.13 (1), p.39-48

2008

Volltextzugriff (PDF)

Shorter pill-free interval in combined oral contraceptives decreases follicular development

Contraception (Stoneham), 1996-08, Vol.54 (2), p.71-77

1996

Volltextzugriff (PDF)

Effect of age on the response of the hypothalamo-pituitary-ovarian axis to a combined oral contraceptive

Fertility and sterility, 1999-06, Vol.71 (6), p.1079-1084

1999

Volltextzugriff (PDF)

Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over three cycles

Fertility and sterility, 2010-09, Vol.94 (4), p.1195-1201

2010

Volltextzugriff (PDF)

Dose finding in a low-dose 21-day combined oral contraceptive containing gestodene

Contraception (Stoneham), 2001-10, Vol.64 (4), p.243-248

2001

Volltextzugriff (PDF)

Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinylestradiol

Contraception (Stoneham), 1996-11, Vol.54 (5), p.299-304

1996

Volltextzugriff (PDF)

Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17β-estradiol

Fertility and sterility, 1993-10, Vol.60 (4), p.616-619

1993

Volltextzugriff (PDF)

HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer

Oncogene, 1989-01, Vol.4 (1), p.109-114

1989

Volltextzugriff (PDF)

Radioisotope in Geburtshilfe und Gynäkologie

1, 1977

Volltextzugriff (PDF)

Modulation of ovarian function by an oral contraceptive containing 30 μg ethinyl estradiol in combination with 2.00 mg dienogest

Contraception (Stoneham), 1997-09, Vol.56 (3), p.185-191

1997

Volltextzugriff (PDF)

Antiandrogen-Estrogen Therapy for Signs of Androgenization

2019

Volltextzugriff (PDF)

Agnus Castus Extracts Inhibit Prolactin Secretion of Rat Pituitary Cells

Hormone and metabolic research, 1993-05, Vol.25 (5), p.253-255

1993

Volltextzugriff (PDF)

A preliminary study on the changes in some potential markers of muscle-cell degradation in sub-maximally exercised horses supplemented with a protein and amino acid mixture: Markers for equine work-induced muscle breakdown

Journal of animal physiology and animal nutrition, 2011-10, Vol.95 (5), p.664-675

2011

Volltextzugriff (PDF)

A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer

Breast cancer research and treatment, 1995, Vol.36 (1), p.11-21

1995

Volltextzugriff (PDF)

Dienogest: A Viewpoint by J. Spona

Drugs (New York, N.Y.), 1998, Vol.56 (5), p.834-835

Spona, J

1998

Volltextzugriff (PDF)

Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 μg ethinyl estradiol and 2.00 mg dienogest on the hemostatic system

Contraception (Stoneham), 1997-08, Vol.56 (2), p.67-75

1997

Volltextzugriff (PDF)

Ovulationshemmung durch SH B 209 AE (Diane ®-35) : Eine neue Antiandrogen-Östrogen- Kombination

Antiandrogen-Östrogentherapie bei Androgenisierungserscheinungen, 2019, p.53-60

Originally published 1987, 2019

Volltextzugriff (PDF)

Androgenic action of progestins and possible synandrogenic properties of antiandrogens used in oral contraceptives

Gynecologic and obstetric investigation, 1984-01, Vol.17 (2), p.66-72

Spona, J

1984

Volltextzugriff (PDF)

Correlation between Genotype and Phenotype in Patients with Cystic Fibrosis

The New England journal of medicine, 1993-10, Vol.329 (18), p.1308-1313

1993

Volltextzugriff (PDF)

LH-RH interaction with the pituitary plasma membrane

FEBS letters, 1973-08, Vol.34 (1), p.24-26

Spona, J.

1973

Volltextzugriff (PDF)

A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation

Advances in contraception, 1994-03, Vol.10 (1), p.5-18

1994

Volltextzugriff (PDF)

1 – 25 von 450

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(333)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Englisch
(252)
Deutsch
(203)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(267)
Female
(265)
Science & Technology
(172)
Life Sciences & Biomedicine
(169)
Adult
(122)
Male
(81)
Biological And Medical Sciences
(70)
Luteinizing Hormone - Blood
(70)
Medical Sciences
(66)
Middle Aged
(63)
Animals
(54)
Pregnancy
(52)
Estradiol - Blood
(45)
Follicle Stimulating Hormone - Blood
(45)
Obstetrics & Gynecology
(44)
Aged
(42)
Radioimmunoassay
(42)
Rats
(42)
Adolescent
(41)
Prolactin - Blood
(40)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity

effects of short intensive exercise on plasma free amino acids in standardbred trotters

preliminary study on the changes in some potential markers of muscle‐cell degradation in sub‐maximally exercised horses supplemented with a protein and amino acid mixture

Changes in intramuscular amino acid levels in submaximally exercised horses - a pilot study

Contraceptive efficacy and safety of a low-dose oral contraceptive, (0.03 mg ethinyl oestradiol and 2 mg chlormadinone acetate) Belara®, over three medication cycles

Shorter pill-free interval in combined oral contraceptives decreases follicular development

Effect of age on the response of the hypothalamo-pituitary-ovarian axis to a combined oral contraceptive

Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over three cycles

Dose finding in a low-dose 21-day combined oral contraceptive containing gestodene

Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinylestradiol

Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17β-estradiol

HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer

Radioisotope in Geburtshilfe und Gynäkologie

Modulation of ovarian function by an oral contraceptive containing 30 μg ethinyl estradiol in combination with 2.00 mg dienogest

Antiandrogen-Estrogen Therapy for Signs of Androgenization

Agnus Castus Extracts Inhibit Prolactin Secretion of Rat Pituitary Cells

A preliminary study on the changes in some potential markers of muscle-cell degradation in sub-maximally exercised horses supplemented with a protein and amino acid mixture: Markers for equine work-induced muscle breakdown

A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer

Dienogest: A Viewpoint by J. Spona

Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 μg ethinyl estradiol and 2.00 mg dienogest on the hemostatic system

Ovulationshemmung durch SH B 209 AE (Diane ®-35) : Eine neue Antiandrogen-Östrogen- Kombination

Androgenic action of progestins and possible synandrogenic properties of antiandrogens used in oral contraceptives

Correlation between Genotype and Phenotype in Patients with Cystic Fibrosis

LH-RH interaction with the pituitary plasma membrane

A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation

Suchergebnisse filtern